CCM Investment Advisers LLC decreased its position in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 3.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 42,198 shares of the semiconductor company’s stock after selling 1,722 shares during the quarter. CCM Investment Advisers LLC’s holdings in Lam Research were worth $9,016,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in LRCX. Fideuram Asset Management Ireland dac acquired a new stake in Lam Research in the fourth quarter valued at about $10,035,000. Generali Investments Management Co LLC increased its position in Lam Research by 62.0% during the 4th quarter. Generali Investments Management Co LLC now owns 36,274 shares of the semiconductor company’s stock worth $6,209,000 after purchasing an additional 13,878 shares during the period. Rokos Capital Management LLP lifted its holdings in shares of Lam Research by 42.0% in the 1st quarter. Rokos Capital Management LLP now owns 259,921 shares of the semiconductor company’s stock valued at $55,532,000 after buying an additional 76,840 shares during the period. Aware Super Pty Ltd as trustee of Aware Super acquired a new stake in shares of Lam Research in the first quarter valued at about $59,973,000. Finally, Krilogy Financial LLC grew its holdings in shares of Lam Research by 19.5% in the 1st quarter. Krilogy Financial LLC now owns 28,111 shares of the semiconductor company’s stock worth $6,006,000 after acquiring an additional 4,584 shares during the period. Hedge funds and other institutional investors own 84.61% of the company’s stock.
Key Lam Research News
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Lam Research reported record quarterly revenue of $6.72 billion, up 30% year over year, while adjusted earnings of $1.82 per share exceeded the $1.69 consensus estimate. Strong NAND demand and record Customer Support revenue were key contributors. Reuters: Chip equipment maker Lam Research forecasts strong revenue on AI boom
- Positive Sentiment: The company guided for fiscal first-quarter 2027 revenue of approximately $7.7 billion to $8.5 billion and EPS of $2.00 to $2.30, well above analyst expectations of roughly $7.0 billion in revenue and $1.81 EPS. The forecast suggests momentum is carrying into 2027. Seeking Alpha: Lam Research pops up after Q4 revenue jumps 30%; outlook smashes estimates
- Positive Sentiment: Management cited accelerating AI-related demand across memory, advanced packaging and wafer-fabrication equipment. Analysts characterized the company as having an “extraordinary runway” into 2027, and Needham raised its EPS estimates while reaffirming a Buy rating and $390 price target. Benzinga: Needham raises Lam Research EPS estimates
- Neutral Sentiment: Morgan Stanley lowered its target to $367 from $404 but maintained an Overweight rating; B. Riley also reduced its target to $350 while retaining a Buy rating. The cuts may reflect valuation or risk-management concerns rather than a deterioration in the earnings outlook.
- Negative Sentiment: Recent insider activity shows executives have been sellers, with no reported open-market purchases in the past six months. Broader risks include semiconductor cyclicality, China-related equipment restrictions and elevated valuation after the rally.
Lam Research Trading Up 18.1%
Lam Research (NASDAQ:LRCX – Get Free Report) last announced its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.69 by $0.13. The firm had revenue of $6.72 billion for the quarter, compared to analysts’ expectations of $6.66 billion. Lam Research had a return on equity of 71.15% and a net margin of 31.27%.Lam Research’s quarterly revenue was up 30.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Sell-side analysts anticipate that Lam Research Corporation will post 7.92 EPS for the current fiscal year.
Lam Research Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 8th. Investors of record on Wednesday, June 17th were paid a dividend of $0.26 per share. The ex-dividend date of this dividend was Wednesday, June 17th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.3%. Lam Research’s dividend payout ratio (DPR) is presently 19.62%.
Analyst Ratings Changes
Several brokerages recently issued reports on LRCX. JPMorgan Chase & Co. lifted their price objective on Lam Research from $300.00 to $315.00 and gave the stock an “overweight” rating in a report on Thursday, April 23rd. Seaport Research Partners initiated coverage on Lam Research in a report on Monday, May 4th. They issued a “buy” rating and a $300.00 target price on the stock. New Street Research raised their price target on Lam Research from $235.00 to $280.00 and gave the company a “neutral” rating in a research report on Monday, April 27th. Raymond James Financial set a $425.00 price target on Lam Research in a research report on Wednesday, June 10th. Finally, Jefferies Financial Group set a $335.00 price target on Lam Research and gave the stock a “buy” rating in a research note on Thursday. One research analyst has rated the stock with a Strong Buy rating, twenty-seven have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $358.47.
Get Our Latest Stock Report on LRCX
Insider Activity at Lam Research
In related news, Director Eric Brandt sold 54,500 shares of Lam Research stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the sale, the director owned 199,205 shares in the company, valued at approximately $69,881,114. This trade represents a 21.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the business’s stock in a transaction dated Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the transaction, the director directly owned 87,142 shares of the company’s stock, valued at $29,192,570. The trade was a 17.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 80,441 shares of company stock valued at $27,614,296 over the last quarter. Insiders own 0.31% of the company’s stock.
About Lam Research
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
See Also
- Five stocks we like better than Lam Research
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
